EBV-Associated LPD — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — EBV-associated lymphoproliferative disorder / immunosuppression-related lymphoma
EBV-associated lymphoproliferative disorder (LPD) is a recognised complication of chronic immunosuppression (particularly Azathioprine combined with other immunosuppressants). Uncontrolled EBV-driven B-cell proliferation results from impaired T-cell surveillance. The spectrum ranges from reactive lymphoid hyperplasia to frank lymphoma. Management includes reduction or cessation of immunosuppression and haematology/oncology referral. Rituximab (anti-CD20) and chemotherapy may be required for aggressive disease.
Reference: ECCO 2023 – OIs in IBD; BSH 2023 – LPD